LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza-Reference-Cited by-同舟云学术

LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza

Published:2022-01 Issue:3 Volume:11 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin & Trans Imm

Author:

Williams Clare M¹,Roy Sreeja¹,Sun Wei¹,Furuya Andrea M²,Wijesundara Danushka K³,Furuya Yoichi¹

Affiliation:

1. Department of Immunology and Microbial Disease Albany Medical College Albany NY USA

2. Pictor Limited Auckland New Zealand

3. The School of Chemistry and Molecular Biosciences The Australian Institute for Bioengineering and Nanotechnology The University of Queensland Brisbane QLD Australia

Funder

National Institutes of Health

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1381

Reference66 articles.

1. Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine

2. Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection.

3. IFN-γ increases susceptibility to influenza A infection through suppression of group II innate lymphoid cells

4. Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections

5. A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early innate cell interactions with Mycobacterium tuberculosis in protection and pathology of tuberculosis;Frontiers in Immunology;2023-10-27

2. Technologies and therapeutics for ongoing prevention of respiratory infections;Clinical & Translational Immunology;2023-01